Article
Genetic variants of CHRNA5-A3 and CHRNB3-A6 predict survival of patients with advanced non-small cell lung cancer.
Oncotarget - 3 May 2016
Wang Yang, Peng Xiaonu, Zhu Lijun, Hu Likuan, Song Yipeng
Abstract excerpt
Nicotinic acetylcholine receptors (nAChRs) play a key role in carcinogenesis and progression of lung cancer; and polymorphisms in CHRNA5-A3 and CHRNB3-A6, two gene clusters encoding nAChR subunits, have been associated with lung cancer risk. In this study, we investigated whether variants in the two gene clusters were associated with prognosis of advanced non-small cell lung cancer (NSCLC). A total of 165 stage...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
